India has a heavy TB burden but has the technological capacity to deal with it. T.V. Padma reports.

Researchers are stepping up efforts to finding new treatments for Chagas disease, with three drug candidates in clinical trials.

The recent nuclear scare in Japan has reinforced pressure in China to raise its awareness of the risks of new technologies. Li Jiao reports.

New vaccines normally take years to reach developing countries, but the WHO hopes it can shorten the time drastically for dengue vaccine.

Mosquitoes are growing resistant to pyrethroids, the only WHO-approved insecticides used in bednets.

Priya Shetty explores the tools and partnerships that help the public health community counter the threat of counterfeit medicines.

New TB vaccines are facing a major funding shortfall, says Mićo Tatalović, and some countries seem resistant to accepting a future vaccine.

Scientists say that Bangladesh's Nipah virus could be stopped by protecting the date palm sap that its fruit bat carriers enjoy.

Thirty years since the eradication of smallpox, we are yet to beat polio and malaria, and scientists are discussing new courses of action.

Can developing countries use nanotechnology to improve health? Priya Shetty looks at nanomedicine's promise.

South Africa is using nanotechnology to improve existing tuberculosis drugs. Munyaradzi Makoni looks at a developing country's experience.

A microbicide gel showed promise for the first time this year, but a range of HIV prevention could hit shelves in the next few years.

While great advances have been made in the lab, GM mosquitoes are still a long way from being airborne, reports Katherine Nightingale.

A successful vaccine trial, new drugs, and improved understanding have given new hope to the HIV/AIDS research community.

Traditional and modern medicine have much to offer each other despite their differences. Priya Shetty assesses an uneasy relationship.

A healthy diet is more than just calories. Priya Shetty gets the figures on the cost of poor nutrition — and the scale of the challenge.

University scientists say they were under-used during the flu crisis because of a poor relationship with government laboratories.

Priya Shetty explains the links between climate change and insect-borne disease, and outlines priorities for developing country policymakers.

Modelling how climate change might affect insect-borne disease is hugely complex — and increasingly controversial, explains Justine Davies.

Many HIV vaccines and microbicides have failed clinical trials and HIV researchers say the field needs to get back to basics.